Status: Baseline only
Reduce the rate of acute hepatitis B
Baseline: 1.1 cases of acute hepatitis B per 100,000 population were reported in 2017
Target: 0.9 cases of acute hepatitis B per 100,000 population
Thousands of people get acute hepatitis B in the United States every year. While the infection can go away, some people develop a lifelong infection and are at increased risk for liver disease, cirrhosis, and liver cancer. Making sure all infants, children, and at-risk adults get the hepatitis B vaccine can help reduce the rate of acute hepatitis B nationwide.